Federal Supply Schedule 36F79722D0224

This Federal Supply Schedule contract was awarded to Idorsia Pharmaceuticals US Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and related products. The contract, valued at up to $300,000, was issued by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to provide drugs, pharmaceuticals, and hematology-related products over a five-year period ending in September 2027. This indefinite delivery vehicle allows the VA to easily procure a range of critical medications, including specialized sleep-regulating orexin inhibitors, to support the healthcare needs of veterans through the VA's Pharmaceutical Prime Vendor Program. The contract was awarded without any set-aside requirements and on a multiple-award basis, facilitating competition among vendors to supply these essential pharmaceutical products to the VA. This agreement builds on a prior interim $25,000 contract under the same Federal Supply Schedule, demonstrating the VA's ongoing need for reliable access to a diverse portfolio of medications to serve veteran patients across the region.